Skip to content

Laparoscopic-assisted Versus Ultrasonography-guided Transversus Abdominis Plane Block in Laparoscopic Sleeve Gastrectomy

Laparoscopic-assisted Versus Ultrasonography-guided Transversus Abdominis Plane Block in Laparoscopic Sleeve Gastrectomy

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06345248
Enrollment
74
Registered
2024-04-03
Start date
2024-04-01
Completion date
2025-05-01
Last updated
2024-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transversus Abdominis Plane

Brief summary

The transversus abdominis plane (TAP) block, whereby local anesthetic is injected between the internal oblique and transversus abdominis fascia to facilitate blockade of somatic afferents nerves, is an effective, non-narcotic adjunct incorporated into many ERAS protocols. We hypothesized that surgeon delivered LAP-TAPs would be non-inferior to anesthesia-delivered US-TAPs in terms of post-operative pain control

Interventions

PROCEDUREUS-TAP

regional block team under ultrasound guidance

PROCEDURELAPTAP

performed TAP block under direct visualization with the laparoscope

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Elective laparoscopic sleeve gastrectomy aging \> 18years BMI \> 40 kg/m2, ASA score I-III

Exclusion criteria

history of chronic opioid consumption suffering from contraindications to regional blocks suffering from allergy to study drugs, history of prior complex abdominal wall reconstruction

Design outcomes

Primary

MeasureTime frameDescription
morphine neededUP TO 24 HOUREmg

Secondary

MeasureTime frameDescription
first analgesic request timeup to 24 hourshe time elapsed between the end of the operation till the first analgesic dose
patients' satisfactionUP TO 24 HOUREscale of 1-4 (1, poor; 2, acceptable; 3, satisfactory; and 4, excellent)
opioid-associated side effectsUP TO 24 HOUREbradycardia and hypotesion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026